MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Motor phenotype classification in moderate to advanced PD: Data from the BioFIND study

    L. Luo, H.F. Andrews, J.G. Goldman, R.N. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, A. Amara, S. Frank, A. Rudolph, C. Casaceli, K. Gwinn, M. Sutherland, C. Kopil, L. Vincent, M. Frasier, U.J. Kang (New York, NY, USA)

    Objective: To evaluate the validity of motor phenotype classification in response to dopaminergic agents in moderate to advanced Parkinson's disease (PD) patients enrolled in the…
  • 2016 International Congress

    Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research

    I. Feldman, M. Afek, L. Bataille (Gedera, Israel)

    Objective: To enable a simple strategy for the continuous collection and analysis of sensory data from Parkinson's disease (PD) patients that can increase the effectiveness…
  • 2016 International Congress

    Changes of speech after neurostimulation for Parkinson’s disease with early fluctuations: A 2-years randomized controlled trial (earlystim-speech)

    S. Pinto, A. Nebel, R. Espesser, J. Rau, P. Maillochon, O. Krack, K. Knudsen, A. Ghio, O. Niebuhr, Y. Agid, M. Schüpbach, G. Deuschl (Aix-en-Provence, France)

    Objective: To assess the effect of subthalamic deep brain stimulation (STN-DBS) on speech in Parkinson's disease patients with early fluctuations and dyskinesia. Background: The effect…
  • 2016 International Congress

    RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)

    P. Roa, P. Stoeter, E. Perez, M. Santana (Santo Domingo, Dominican Republic)

    Objective: To evaluate the safety and potential efficacy of RE-024 in open treatment of 2 patients with PKAN. Background: PKAN is an autosomal recessive, neurodegenerative…
  • 2016 International Congress

    Two years after unilateral Forel’s H campotomy for Parkinson’s disease: Quality of life, motor and cognitive outcomes of eleven patients

    F. Godinho, M.O. Oliveira, P. Terzian, C. Costa, P. Gordon, M.S. Rocha (São Paulo, Brazil)

    Objective: To provide a thorough assessment of the effects of unilateral Forel's H campotomy on Parkinson's disease patients. Background: Since its proposal in 1963, Forel's…
  • 2016 International Congress

    Efficiency of intraoperative microelectrode recording in patients with deep brain stimulation of the subthalamic nucleus. Three-year comparative research

    N. Gubareva, E. Bril, A. Tomskiy, N. Fedorova, S. Asriyants (Moscow, Russia)

    Objective: The aim of the study was to evaluate the effect of intraoperative microelectrode recording in patients with deep brain stimulation of the subthalamic nucleus…
  • 2016 International Congress

    Comparison of effect of variable deep brain stimulation (DBS) frequencies on gait and balance in Parkinson’s disease (PD) patients with either bilateral GPi or STN stimulators employing wearable wireless sensors

    A. Deep, A. Lieberman, R. Dhall, T. Lockhart, C. Frames, S. Shafer, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi (Phoenix, AZ, USA)

    Objective: To compare the effect of variable Deep brain Stimulation (DBS) frequencies on gait and balance in Parkinson's disease (PD) patients with either bilateral GPi…
  • 2016 International Congress

    How do patients experience deep brain stimulation surgery: A prospective patient satisfaction survey

    A. Fazl, M. Gillego, A. Mogliner, M.H. Pourfar (New York, NY, USA)

    Objective: To evaluate experience of patients who undergo Deep Brain Stimulation (DBS) surgery for treatment of different movement disorders, using patient survey questionnaires. Background: DBS…
  • 2016 International Congress

    Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

    M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

    Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress…
  • 2016 International Congress

    Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

    F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

    Objective: To test whether subjective sleep perception is associated with objective sleep parameters by comparing video-polysomnographic (vPSG) data from Parkinson's disease (PD) patients with scorings…
  • « Previous Page
  • 1
  • …
  • 374
  • 375
  • 376
  • 377
  • 378
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #24475 (not found)
  • Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley